Choose Language
Select a language for news translation.
A study finds combining apitegromab with tirzepatide may help preserve lean muscle while supporting weight loss in people with obesity.
Tyrannosaurus rex may have been a much slower grower than scientists realized. A new study of 17 tyrannosaur fossils found that the giant predator likely took …
You come home after a stressful day and reach out to your cat for a bit of comfort. It hisses. Maybe takes a swipe. Or simply flicks its tail and saunters off …
A study of long-lived families has identified rare genetic variants that may help people stay healthier for much longer as they age. One standout mutation appe…
New research outlines how chatbot behaviors, including personalization, mirroring, and excessive agreement, reinforce delusions.
Preliminary study finds that testosterone levels increase or stabilize in people taking GLP-1 medications The latest generation of obesity drugs might have an…
A long-term Yale study is challenging one of the biggest myths about aging. Nearly half of adults over 65 improved physically, mentally, or both over time, des…
A study published by Food Research International analyzed the triple effect of climate change on soybean quality—increased carbon dioxide (CO₂), high temperatu…
The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozemp…
The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozemp…
A recent SmartAsset study revealed the income needed to be considered middle class in every US state. See where yours falls.
